323 related articles for article (PubMed ID: 32224436)
21. Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma.
Yuan Q; Chen BH; Huang DJ; Zhang R
Braz J Med Biol Res; 2023; 56():e12638. PubMed ID: 37493769
[TBL] [Abstract][Full Text] [Related]
22. EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.
Chang PY; Wu ZZ; Sun NK; Chao CC
J Cell Physiol; 2014 Mar; 229(3):309-22. PubMed ID: 23939952
[TBL] [Abstract][Full Text] [Related]
23. Novel roles and therapeutic targets of Epstein-Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma.
Tao Y; Shi Y; Jia J; Jiang Y; Yang L; Cao Y
Expert Rev Mol Med; 2015 Aug; 17():e15. PubMed ID: 26282825
[TBL] [Abstract][Full Text] [Related]
24. Exosomal cyclophilin A as a novel noninvasive biomarker for Epstein-Barr virus associated nasopharyngeal carcinoma.
Liu L; Zuo L; Yang J; Xin S; Zhang J; Zhou J; Li G; Tang J; Lu J
Cancer Med; 2019 Jun; 8(6):3142-3151. PubMed ID: 31063269
[TBL] [Abstract][Full Text] [Related]
25. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis.
Li J; Zhang Y; Sun L; Liu S; Zhao M; Luo B
Microbiol Spectr; 2022 Jun; 10(3):e0000622. PubMed ID: 35674441
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus-driven metabolic alterations contribute to the viral lytic reactivation and tumor progression in nasopharyngeal carcinoma.
Shi F; Shang L; Zhou M; Lv C; Li Y; Luo C; Liu N; Lu J; Tang M; Luo X; Xu J; Fan J; Zhou J; Gao Q; Wu W; Jia W; Wang H; Cao Y
J Med Virol; 2024 May; 96(5):e29634. PubMed ID: 38682578
[TBL] [Abstract][Full Text] [Related]
27. Capn4 is induced by and required for Epstein-Barr virus latent membrane protein 1 promotion of nasopharyngeal carcinoma metastasis through ERK/AP-1 signaling.
Zheng P; Chen X; Xie J; Chen X; Lin S; Ye L; Chen L; Lin J; Yu X; Zheng M
Cancer Sci; 2020 Jan; 111(1):72-83. PubMed ID: 31691433
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-encoded LMP1 interacts with FGD4 to activate Cdc42 and thereby promote migration of nasopharyngeal carcinoma cells.
Liu HP; Chen CC; Wu CC; Huang YC; Liu SC; Liang Y; Chang KP; Chang YS
PLoS Pathog; 2012; 8(5):e1002690. PubMed ID: 22589722
[TBL] [Abstract][Full Text] [Related]
29. EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy.
Fang W; Zhang J; Hong S; Zhan J; Chen N; Qin T; Tang Y; Zhang Y; Kang S; Zhou T; Wu X; Liang W; Hu Z; Ma Y; Zhao Y; Tian Y; Yang Y; Xue C; Yan Y; Hou X; Huang P; Huang Y; Zhao H; Zhang L
Oncotarget; 2014 Dec; 5(23):12189-202. PubMed ID: 25361008
[TBL] [Abstract][Full Text] [Related]
30. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells.
Lo AK; Lo KW; Ko CW; Young LS; Dawson CW
J Pathol; 2013 Jul; 230(3):336-46. PubMed ID: 23592276
[TBL] [Abstract][Full Text] [Related]
32. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW
J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of ATOH8 induced by EBV-encoded LMP1 contributes to the malignant phenotype of nasopharyngeal carcinoma.
Wang Z; Xie J; Yan M; Wang J; Wang X; Zhang J; Zhang Y; Li P; Lei X; Huang Q; Lin S; Guo X; Liu Q
Oncotarget; 2016 May; 7(18):26765-79. PubMed ID: 27049918
[TBL] [Abstract][Full Text] [Related]
34. EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma.
Lu J; Tang M; Li H; Xu Z; Weng X; Li J; Yu X; Zhao L; Liu H; Hu Y; Tan Z; Yang L; Zhong M; Zhou J; Fan J; Bode AM; Yi W; Gao J; Sun L; Cao Y
Cancer Lett; 2016 Sep; 380(1):191-200. PubMed ID: 27255972
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.
Yang GD; Huang TJ; Peng LX; Yang CF; Liu RY; Huang HB; Chu QQ; Yang HJ; Huang JL; Zhu ZY; Qian CN; Huang BJ
PLoS One; 2013; 8(10):e78355. PubMed ID: 24194922
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of endocan by Epstein-Barr virus latent membrane protein 1 and its clinical significance in nasopharyngeal carcinoma.
Yu PH; Chou SF; Chen CL; Hung H; Lai CY; Yang PM; Jeng YM; Liaw SF; Kuo HH; Hsu HC; Chen JY; Wang WB
PLoS One; 2013; 8(12):e82254. PubMed ID: 24340011
[TBL] [Abstract][Full Text] [Related]
37. Targeting EZH2 depletes LMP1-induced activated regulatory T cells enhancing antitumor immunity in nasopharyngeal carcinoma.
Sun W; Chen L; Tang J; Zhang C; Wen Y; Wen W
J Cancer Res Ther; 2020; 16(2):309-319. PubMed ID: 32474518
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
Lechner M; Schartinger VH; Steele CD; Nei WL; Ooft ML; Schreiber LM; Pipinikas CP; Chung GT; Chan YY; Wu F; To KF; Tsang CM; Pearce W; Morelli D; Philpott M; Masterson L; Nibhani R; Wells G; Bell CG; Koller J; Delecluse S; Yip YL; Liu J; Forde CT; Forster MD; Jay A; Dudás J; Krapp A; Wan S; Uprimny C; Sprung S; Haybaeck J; Fenton TR; Chester K; Thirlwell C; Royle G; Marafioti T; Gupta R; Indrasari SR; Herdini C; Slim MAM; Indrawati I; Sutton L; Fles R; Tan B; Yeong J; Jain A; Han S; Wang H; Loke KSH; He W; Xu R; Jin H; Cheng Z; Howard D; Hwang PH; Le QT; Tay JK; West RB; Tsao SW; Meyer T; Riechelmann H; Oppermann U; Delecluse HJ; Willems SM; Chua MLK; Busson P; Lo KW; Wollmann G; Pillay N; Vanhaesebroeck B; Lund VJ
Nat Commun; 2021 Jan; 12(1):117. PubMed ID: 33402692
[TBL] [Abstract][Full Text] [Related]
39. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea.
Jeon YK; Lee BY; Kim JE; Lee SS; Kim CW
Head Neck; 2004 Jul; 26(7):573-83. PubMed ID: 15229899
[TBL] [Abstract][Full Text] [Related]
40. Tyrosylprotein sulfotransferase-1 and tyrosine sulfation of chemokine receptor 4 are induced by Epstein-Barr virus encoded latent membrane protein 1 and associated with the metastatic potential of human nasopharyngeal carcinoma.
Xu J; Deng X; Tang M; Li L; Xiao L; Yang L; Zhong J; Bode AM; Dong Z; Tao Y; Cao Y
PLoS One; 2013; 8(3):e56114. PubMed ID: 23472069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
